Correlation between interleukin-6 levels and methadone maintenance therapy outcomes

Area of Science:

• Neuroscience
• Immunology
• Psychiatry

Background:

• Opioid use disorder (OUD) is linked to inflammation and reduced neurotrophic factors, potentially hindering recovery.
• Methadone maintenance therapy (MMT) outcomes vary, suggesting underlying biological factors influence treatment success.

Purpose of the Study:

• To investigate the correlation between inflammatory markers, neurotrophic factors, and MMT outcomes in OUD patients.
• To determine if specific cytokine and brain-derived neurotrophic factor (BDNF) levels predict treatment success or failure.

Main Methods:

• 104 OUD patients undergoing MMT were monitored for 12 weeks.
• Plasma levels of TNF-α, CRP, IL-6, IL-1β, TGF-β1, BDNF, and morphine were measured serially.
• Statistical analyses, including GEE, examined associations between biomarkers and MMT outcomes.

Main Results:

• Plasma levels of CRP, TGF-β1, and BDNF decreased during MMT.
• Elevated IL-6 levels significantly correlated with higher plasma morphine, positive urinary tests, poor compliance, and early dropout.
• Other measured cytokines and BDNF showed no consistent association with MMT outcomes.

Conclusions:

• Higher IL-6 levels are associated with adverse MMT outcomes in OUD patients.
• Targeting IL-6 may represent a novel therapeutic strategy to enhance MMT efficacy.
• Further research into IL-6 regulation for improving OUD treatment is warranted.